Investment analysts at Goldman Sachs Group assumed coverage on shares of HCA Healthcare (NYSE:HCA) in a research report issued on Wednesday, The Fly reports. The brokerage set a “neutral” rating on the stock.
Several other brokerages also recently commented on HCA. BMO Capital Markets started coverage on HCA Healthcare in a research note on Monday, October 16th. They issued an “outperform” rating and a $90.00 price objective for the company. ValuEngine downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Thursday, September 7th. Robert W. Baird set a $86.00 price objective on HCA Healthcare and gave the stock a “buy” rating in a research note on Thursday, October 19th. Citigroup raised HCA Healthcare from a “neutral” rating to a “buy” rating in a research note on Tuesday, December 12th. Finally, KeyCorp reissued an “overweight” rating and issued a $90.00 price objective (down from $95.00) on shares of HCA Healthcare in a research note on Thursday, October 19th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and eighteen have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $87.45.
Shares of HCA Healthcare (HCA) opened at $89.51 on Wednesday. The company has a market capitalization of $31,099.97, a P/E ratio of 12.73, a PEG ratio of 1.18 and a beta of 0.55. HCA Healthcare has a 52 week low of $71.18 and a 52 week high of $91.03. The company has a quick ratio of 1.41, a current ratio of 1.68 and a debt-to-equity ratio of -6.46.
In other HCA Healthcare news, SVP Victor L. Campbell sold 8,000 shares of the stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $75.82, for a total transaction of $606,560.00. Following the completion of the transaction, the senior vice president now directly owns 127,275 shares of the company’s stock, valued at $9,649,990.50. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of the stock in a transaction on Tuesday, October 17th. The shares were sold at an average price of $78.00, for a total value of $167,700.00. Following the transaction, the insider now directly owns 12,476 shares of the company’s stock, valued at $973,128. The disclosure for this sale can be found here. Insiders have sold 22,700 shares of company stock valued at $1,773,872 over the last ninety days. 2.90% of the stock is currently owned by company insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in HCA. Strs Ohio boosted its holdings in shares of HCA Healthcare by 12.2% in the third quarter. Strs Ohio now owns 1,075,778 shares of the company’s stock worth $85,621,000 after acquiring an additional 117,000 shares during the period. Magellan Asset Management Ltd bought a new position in shares of HCA Healthcare in the second quarter worth $489,097,000. Numeric Investors LLC boosted its holdings in shares of HCA Healthcare by 527.5% in the fourth quarter. Numeric Investors LLC now owns 25,100 shares of the company’s stock worth $1,858,000 after acquiring an additional 21,100 shares during the period. Northwestern Mutual Investment Management Company LLC boosted its holdings in shares of HCA Healthcare by 29.9% in the second quarter. Northwestern Mutual Investment Management Company LLC now owns 775,914 shares of the company’s stock worth $59,753,000 after acquiring an additional 178,792 shares during the period. Finally, First Financial boosted its holdings in shares of HCA Healthcare by 7.7% in the fourth quarter. First Financial now owns 4,910 shares of the company’s stock worth $332,000 after acquiring an additional 350 shares during the period. 75.34% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: “HCA Healthcare (HCA) Coverage Initiated by Analysts at Goldman Sachs Group” was originally published by American Banking and Market News and is the property of of American Banking and Market News. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2018/01/03/hca-healthcare-hca-coverage-initiated-by-analysts-at-goldman-sachs-group.html.
HCA Healthcare Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
